BRIGHT MINDS BIOSCIENCES INC. (DRUG) reporting calendar
BRIGHT MINDS BIOSCIENCES INC. files periodic reports with the SEC as DRUG on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 40-F
- Period ended
- 30 Sep 2025
- Filed
- 23 Dec 2025
- Reports on record
- 5
Open DRUG market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 40-F | 30 Sep 2025 | 23 Dec 2025 | 84 days | 0001437749-25-038729 |
| 20-F | 30 Sep 2024 | 31 Dec 2024 | 92 days | 0001062993-24-021301 |
| 20-F | 30 Sep 2023 | 29 Dec 2023 | 90 days | 0001062993-23-023281 |
| 20-F | 30 Sep 2022 | 29 Dec 2022 | 90 days | 0001062993-22-024547 |
| 20-F | 30 Sep 2021 | 29 Dec 2021 | 90 days | 0001062993-21-013611 |
Source: SEC EDGAR company submissions for CIK 0001827401. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.